Range
- - -
Vol / Avg.
-/309.7K
Div / Yield
-
52 Wk
25.41 - 62.79
Mkt Cap
2.1B
Payout Ratio
-
Open
-
P/E
-
EPS
-1.24
Shares
41.3M
Outstanding
41.3M
Total Float
26.9M
Benzinga - Nov 9, 2020, 7:22AM
load more
Sector: Health Care.Industry: Biotechnology
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. The company has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-1.240
REV0
Q4 2020Est.ActualSurprise
EPS-1.010
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ZNTLZentalis Pharmaceuticals0%2.1B

Zentalis Pharmaceuticals Frequently Asked Questions

Q

How do I buy Zentalis Pharmaceuticals (ZNTL) stock?

A

You can purchase shares of Zentalis Pharmaceuticals (NASDAQ: ZNTL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Zentalis Pharmaceuticals's (ZNTL) competitors?

Q

What is the target price for Zentalis Pharmaceuticals (ZNTL) stock?

A

The latest price target for Zentalis Pharmaceuticals (NASDAQ: ZNTL) was reported by UBS on May 21, 2021. The analyst firm set a price target for 91.00 expecting ZNTL to rise to within 12 months (a possible 74.93% upside). 10 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Zentalis Pharmaceuticals (ZNTL)?

A

The stock price for Zentalis Pharmaceuticals (NASDAQ: ZNTL) is $52.02 last updated Thu Jun 24 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Zentalis Pharmaceuticals (ZNTL) pay a dividend?

A

There are no upcoming dividends for Zentalis Pharmaceuticals.

Q

When is Zentalis Pharmaceuticals (NASDAQ:ZNTL) reporting earnings?

A
Zentalis Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 12, 2021.
Q

Is Zentalis Pharmaceuticals (ZNTL) going to split?

A

There is no upcoming split for Zentalis Pharmaceuticals.

Q

What sector and industry does Zentalis Pharmaceuticals (ZNTL) operate in?

A

Zentalis Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.